All In Biotech

Drug Trial Radar · NCT02498782

Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease

Phase 2, Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Six Oral Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease.

Last checked: Nov 20, 2026Latest source record: Jul 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

140

Planned (sponsor's estimate)

Start

Jul 2014

Primary completion

Sep 2015

Study completion Feb 2016

Sponsor

Lead sponsor
Drugs for Neglected DiseasesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 15, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The hypothesis is to evaluate if the treatment with Fexinidazole will lead to a better sustained clearance of the parasites at 6 months of follow-up when in comparison to placebo in patients with chronic indeterminate CD.

Conditions

  • Chagas Disease
  • Trypanosomiasis, South American
  • South American Trypanosomiasis
  • Disease, Chagas

Interventions

  • FexinidazoleDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Parasitological cure rate (PCR)Time frame: 8 weeks and sustained until 6 months
  2. Adverse eventsTime frame: 7 months
  3. Serious Adverse eventsTime frame: 7 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Plataforma Atención Integral de Pacientes con Enfermedad de Chagas

    Cochabamba, Bolivia · Recruiting

  • Plataforma de Atención Integral de Pacientes con Enfermedad de Chagas

    Tarija, Bolivia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.